188 related articles for article (PubMed ID: 24704825)
1. LNK (SH2B3): paradoxical effects in ovarian cancer.
Ding LW; Sun QY; Lin DC; Chien W; Hattori N; Dong XM; Gery S; Garg M; Doan NB; Said JW; Xiao JF; Yang H; Liu LZ; Meng X; Huang RY; Tang K; Koeffler HP
Oncogene; 2015 Mar; 34(11):1463-74. PubMed ID: 24704825
[TBL] [Abstract][Full Text] [Related]
2. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
3. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
[TBL] [Abstract][Full Text] [Related]
4. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.
Chatelais M; Devallière J; Galli C; Charreau B
Xenotransplantation; 2011; 18(2):108-20. PubMed ID: 21496118
[TBL] [Abstract][Full Text] [Related]
6. LNK suppresses interferon signaling in melanoma.
Ding LW; Sun QY; Edwards JJ; Fernández LT; Ran XB; Zhou SQ; Scolyer RA; Wilmott JS; Thompson JF; Doan N; Said JW; Venkatachalam N; Xiao JF; Loh XY; Pein M; Xu L; Mullins DW; Yang H; Lin DC; Koeffler HP
Nat Commun; 2019 May; 10(1):2230. PubMed ID: 31110180
[TBL] [Abstract][Full Text] [Related]
7. LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.
Devallière J; Chatelais M; Fitau J; Gérard N; Hulin P; Velazquez L; Turner CE; Charreau B
FASEB J; 2012 Jun; 26(6):2592-606. PubMed ID: 22441983
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 regulates the LNK/JAK2 pathway in mouse hematopoietic stem and progenitor cells.
Jiang J; Balcerek J; Rozenova K; Cheng Y; Bersenev A; Wu C; Song Y; Tong W
J Clin Invest; 2012 Jun; 122(6):2079-91. PubMed ID: 22546852
[TBL] [Abstract][Full Text] [Related]
9. LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway.
Lv J; Yu W; Zhang Y; Cao X; Han L; Hu H; Wang C
Cancer Cell Int; 2020; 20():124. PubMed ID: 32322171
[TBL] [Abstract][Full Text] [Related]
10. Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.
Looi CY; Imanishi M; Takaki S; Sato M; Chiba N; Sasahara Y; Futaki S; Tsuchiya S; Kumaki S
PLoS One; 2011; 6(8):e23640. PubMed ID: 21853157
[TBL] [Abstract][Full Text] [Related]
11. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
12. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
[TBL] [Abstract][Full Text] [Related]
13. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome.
Hao M; Yuan F; Jin C; Zhou Z; Cao Q; Xu L; Wang G; Huang H; Yang D; Xie M; Zhao X
Endocrinology; 2016 Oct; 157(10):3709-3718. PubMed ID: 27459314
[TBL] [Abstract][Full Text] [Related]
15. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
16. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
[TBL] [Abstract][Full Text] [Related]
17. LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.
Wang W; Tang Y; Wang Y; Tascau L; Balcerek J; Tong W; Levine RL; Welch C; Tall AR; Wang N
Circ Res; 2016 Sep; 119(6):e91-e103. PubMed ID: 27430239
[TBL] [Abstract][Full Text] [Related]
18. Role of the adaptor protein LNK in normal and malignant hematopoiesis.
Gery S; Koeffler HP
Oncogene; 2013 Jun; 32(26):3111-8. PubMed ID: 23045270
[TBL] [Abstract][Full Text] [Related]
19. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo.
Takizawa H; Nishimura S; Takayama N; Oda A; Nishikii H; Morita Y; Kakinuma S; Yamazaki S; Okamura S; Tamura N; Goto S; Sawaguchi A; Manabe I; Takatsu K; Nakauchi H; Takaki S; Eto K
J Clin Invest; 2010 Jan; 120(1):179-90. PubMed ID: 20038804
[TBL] [Abstract][Full Text] [Related]
20. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY
Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
